Skip to main content

Closed

DRMA: Dermata Therapeutics, Inc. Financial Statements & Revenue | finqOS

Healthcare · Biotechnology

52W Range

1thpctl

Volume

1.25×avg

Market Cap

797422USD

P/E Ratio

-0.2TTM

Div Yield

-ann

Dermata Therapeutics, Inc.

DRMANASDAQ Capital Market·USD·Closed

Dermata Therapeutics, Inc.

DRMANASDAQ·USD·Closed

$1.17

−0.85%

$1.17

−$0.01 (0.85%)

52W Range

1thpctl

Volume

1.25×avg

Mkt Cap

797422USD

P/E

-0.2TTM

Div Yield

–ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings